From the Journals

Eating fish tied to fewer CVD events in high-risk people


 

OTC fish oil capsules are ‘very reasonable’

For people who either can’t consume two fish meals a week or want to ensure their omega 3 intake is adequate, “it’s very reasonable for the average person to take one OTC [over-the-counter] fish oil capsule a day,” Dr. Mozaffarian added.

He acknowledged that several studies of fish oil supplements failed to show benefit, but several others have. “It’s a confusing field, but the evidence supports benefit from omega 3s,” he concluded.

He discounted the new finding that only people with established CVD or who are at high-risk benefit. “I’m not sure we should make too much of this, because many prior studies showed a lower CVD risk in fish-eating people without prevalent CVD,” he said. The new study “provides important information given its worldwide breadth.”

The new report used data regarding 191,558 people enrolled prospectively in any of four studies. The average age of the participants was 54 years, and 52% were women.

During follow-up, death from any cause occurred in 6% of those without CVD or CVD risk and in 13% of those with these factors. Major CVD events occurred in 5% and 17% of these two subgroups, respectively. To calculate the relative risks between those who ate fish and those who did not, the investigators used standard multivariate adjustment for potential confounders and adjusted for several dietary variables, Dr. Mente said.

Dr. Mohan and Dr. Mente disclosed no relevant financial relationships. Dr. Mozaffarian has received personal fees from Acasti Pharma, Amarin, America’s Test Kitchen, Barilla, Danone, GEOD, and Motif Food Works, and he has been an adviser to numerous companies.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Coffee lowers heart failure risk in unique study
MDedge Family Medicine
Women and ACS: Focus on typical symptoms to improve outcomes
MDedge Family Medicine
Menopause transition affects heart health risks
MDedge Family Medicine
FDA approves orphan drug evinacumab-dgnb for homozygous FH
MDedge Family Medicine
Myocardial injury seen on MRI in 54% of recovered COVID-19 patients
MDedge Family Medicine
How to convince patients muscle pain isn’t a statin Achilles heel: StatinWISE
MDedge Family Medicine
Big data ‘clinch’ link between high glycemic index diets and CVD
MDedge Family Medicine
No vascular benefit of testosterone over exercise in aging men
MDedge Family Medicine
Heart health in pregnancy tied to CV risk in adolescent offspring
MDedge Family Medicine
Obesity: A ‘double hit’ in pregnant women with heart disease
MDedge Family Medicine